3-Chloro-2-(3-(trifluoromethyl)-1H-pyrazol-1-yl)pyridine, 95%, 100mg

(trans,trans)-4-Pentyl-4'-(3,4,5-trifluorophenyl)-1,1'-bi(cyclohexane), 97.0%, 10g

Dodecylcyclohexane>98.0%(GC)500mL

5-oxo-5-(9-Phenanthryl)valeric acid, 97.0%, 1g

EDTA-Manganese disodium salt x 2H2O, min. 93%, for synthesis, 250 g, plastic packaging.

Yttrium Target 99.9% dia. 50.8 mm x thickness 3.18 mm 1 pc

5-(2,6-Dichlorophenyl)-1H-tetrazole, 97.0%, 1g

4-(2-chlorophenyl)-3-methyl-1H-pyrazol-5-amine, 95.0%, 250mg

Ethyl 5-chloro-1,2-oxazole-3-carboxylate, 97%, 1g

(R)-1-N-Boc-4-N-Boc-Piperazine-2-carboxylic acid, 95.0%, 25g

2-[(4-ethyl-7-methyl-2-oxo-2H-chromen-5-yl)oxy]propanoic acid, 95.0%, 1g

Benzyl (5S)-5-methyl-1,4-diazepane-1-carboxylate, 97%, 100mg

(1R,4S)-1,7,7-Trimethylbicyclo[2.2.1]heptane-2,3-dione, 97%, 5g